Abstract

Omeprazole 2-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2006 - Dermatology

Page(s): 389

Download in electronic PDF format for $75

Abstract

A formulation for preparing Omeprazole 2-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2006 Pg. 389	Omeprazole 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 504-510	Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Sep/Oct 2006 Pg. 391	Pantoprazole Sodium 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 500-512	To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
May/Jun 2023 Pg. 250-255	Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base Author(s): Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2020 Pg. 140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2006 Pg. 382	Famotidine 8-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 164-166	Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Author(s): Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2007 Pg. 161	Ranitidine Hydrochloride 15-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 409	Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F
May/Jun 2010 Pg. 246	Lansoprazole 3-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 139	Cimetidine 60-mg/mL Oral Liquid, Alcohol Free Author(s): Allen Loyd V Jr